Masclee, Gwen M. C.
Snijkers, Johanna T. W.
Boersma, Marijke
Masclee, Ad A. M.
Keszthelyi, Daniel
Article History
Received: 31 May 2021
Accepted: 16 November 2021
First Online: 23 November 2021
Declarations
:
: All subjects gave permission and informed consent for audio recording prior to participation. Informed consent was obtained from all subjects or, if subjects are under 18, from a parent and/or legal guardian. According to Dutch legal regulations, protocols for focus group interviews are not subject to formal review by the ethics committee as determined by the ‘Wet medisch-wetenschappelijk onderzoek met mensen (WMO)’. All study procedures were conducted in accordance with the Declaration of Helsinki and all other relevant guidelines and regulations. Standards for reporting qualitative research (SRQR) were followed [CitationRef removed].
: Not applicable.
: GM, JTWS, MB have no competing interests. AAM has received a ZON MW, The Netherlands Organization for Health Research and Development, health care efficiency grant to evaluate efficacy of peppermint oil in IBS; has received an unrestricted research grant from Will Pharma S.A.; has received from the Dutch Cancer Society related to endoscopy and to colorectal polyps; received funding from Pentax Europe GmBH; received research funding from Allegan and Grünenthal on IBS topics; has given scientific advice to Bayer ( topic: IBS) to Kyowa Kirin (topic: constipation) and to Takeda (topic: gastroparesis). DK has received research funding for the establishment of IBS centers of excellence in the Netherlands. DK has received research funding from Will Pharma, Allergan, Grunenthal, ZonMw, UEG, Rome Foundation, outside of submitted work.